Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2000
11/09/2000WO2000066720A2 The use of adeno-associated virus (aav) deliver cytoprotective genes
11/09/2000WO2000066718A1 Forms of prostate specific antigen (psa) specific for benign prostatic hyperplasia (bph) and methods of using such
11/09/2000WO2000066717A1 Human brain carboxypeptidase b
11/09/2000WO2000066716A2 Method for producing organisms exhibiting increased sterol glycoside production and use of the sterol glycosides
11/09/2000WO2000066715A1 Method for diminishing specific immune reactions
11/09/2000WO2000066709A2 Zymogen activation system
11/09/2000WO2000066708A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
11/09/2000WO2000066632A1 Agonists or antagonists for haemopoietic growth factors
11/09/2000WO2000066631A1 SPECIFIC ANTIBODIES AND ANTIBODY FRAGMENTS FOR TGFβ¿1?
11/09/2000WO2000066630A1 DNA ENCODING SNORF36a AND SNORF36b RECEPTORS
11/09/2000WO2000066627A1 Expression of heparin-binding protein in recombinant mammalian cells
11/09/2000WO2000066623A2 Surrogate cell-based system and method for assaying the activity of hepatitis c virus ns3 protease
11/09/2000WO2000066617A1 Methods for the treatment of neuronal atrophy-associated dementia
11/09/2000WO2000066610A1 Apple promoters for expression of transgenes in plants
11/09/2000WO2000066609A1 Oligonucleotides having a-dna form and b-dna form conformational geometry
11/09/2000WO2000066607A1 Detection using degradation of a tagged sequence
11/09/2000WO2000066606A1 Substrate including anionic detergent for purifying nucleic acid
11/09/2000WO2000066604A2 L-ribo-lna analogues
11/09/2000WO2000066266A1 Sensor for microfluid handling system
11/09/2000WO2000066179A1 Noninvasive genetic immunization, expression products therefrom, and uses thereof
11/09/2000WO2000066178A1 Lim mineralization protein splice variants
11/09/2000WO2000066177A1 GENE THERAPY USING TGF-$g(b)
11/09/2000WO2000066162A1 Mutant human cd80 and compositions for and methods of making and using the same
11/09/2000WO2000066157A1 Proteins expressed by mycobacterium tuberculosis and not by bcg and their use as diagnostic reagents and vaccines
11/09/2000WO2000066156A1 Death domain containing receptor 5
11/09/2000WO2000066154A2 Anti-microbial agents, diagnostic reagents, and vaccines based on unique apicomplexan parasite components
11/09/2000WO2000066148A1 Novel proteins
11/09/2000WO2000066068A2 Method for inducing growth and enhancing survival of nervous tissue
11/09/2000WO2000066067A2 Ibd-associated microbial antigens and methods of using same
11/09/2000WO2000065908A1 Traf5 knockout mouse
11/09/2000WO2000065903A1 Transformation of allium sp. with agrobacterium using embryogenic callus cultures
11/09/2000WO2000053759A8 Expression of human alpha-fetoprotein in mammalian cells
11/09/2000WO2000042195B1 Schizochytrium pks genes
11/09/2000WO2000040705A3 Human desaturase gene and uses thereof
11/09/2000WO2000040592A8 Acid stable backbone modified end-blocked nucleic acids and therapeutic uses thereof
11/09/2000WO2000039323A3 Production of proteins in gram-positive microorganisms
11/09/2000WO2000039307A3 Recombinant bacterial strains for the production of natural nucleosides and modified analogues thereof
11/09/2000WO2000039293A3 Agent for inhibiting the regeneration of tissue
11/09/2000WO2000037663A3 Plant transformation process
11/09/2000WO2000037658A3 Chemically modified enzymes with multiple charged variants
11/09/2000WO2000037645A3 Cell cycle nucleic acids, polypeptides and uses thereof
11/09/2000WO2000037638A3 Methods and compositions for inhibiting neoplastic cell growth
11/09/2000WO2000037094A3 Therapeutic applications of flint polypeptides
11/09/2000WO2000036115A3 Plant carbon catabolite repression proteins
11/09/2000WO2000036102A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/09/2000WO2000036091A3 An animal model for identifying a common stem/progenitor to liver cells and pancreatic cells
11/09/2000WO2000035473A3 Methods for detection and use of differentially expressed genes in disease states
11/09/2000WO2000035421A3 Integrative protein-dna cochleate formulations and methods for transforming cells
11/09/2000WO2000034652A3 Methods of identifying point mutations in a genome
11/09/2000WO2000034497A3 Enhanced packaging of herpes virus amplicons and generation of recombinant virus vectors
11/09/2000WO2000034477A3 Neuron-associated proteins
11/09/2000WO2000034475A3 Grnf4, a gdnf-related neurotrophic factor
11/09/2000WO2000034461A3 Compositions and methods of modulating cholesterol metabolism
11/09/2000WO2000034447A3 Human ubiquitin ligase e3 for the modulation of nf-kappa b
11/09/2000WO2000034438A3 Method for constructing libraries of phenotypic profiles
11/09/2000WO2000032794A3 Chlamydia antigens and corresponding dna fragments and uses thereof
11/09/2000WO2000032630A3 Nucleic acids and polypeptides derived from activated eosinophil cells and use thereof
11/09/2000WO2000032624A3 Uncoupling protein 5 - ucp5
11/09/2000WO2000031306A3 Multiplex amplification of short tandem repeat loci
11/09/2000WO2000031238A3 Methods and reagents for increasing proliferative capacity and preventing replicative senescence
11/09/2000WO2000031236A3 Vectors for gene mutagenesis and gene discovery by gene trapping
11/09/2000WO2000031235A3 Nucleotide and protein sequences of nogo genes and methods based thereon
11/09/2000WO2000030671A3 Nf-at mediates cardiac hypertrophy, methods and reagents related thereto
11/09/2000WO2000029617A3 Water-soluble luminescent quantum dots and bioconjugates thereof
11/09/2000WO2000029597A3 Mutant genes encoding plant adp-glucose pyrophosphorylase and methods of use
11/09/2000WO2000029564A3 Human glycine transporter type 2
11/09/2000WO2000029553A9 Bioengineered tissue constructs and methods for producing and using them
11/09/2000WO2000029429A3 Endoplasmic reticulum stress transcription factors atf6 and creb-rp
11/09/2000WO2000029428A3 5t4 tumour-associated antigen for use in tumour immunotherapy
11/09/2000WO2000029000A9 Compositions and methods for recombinational cloning of nucleic acid molecules
11/09/2000WO2000028036A3 Disease resistance factors
11/09/2000WO2000028034A3 Cytokine signal regulators
11/09/2000WO2000028033A3 Nucleic acids and polypeptides having altered expression in the t84 gut barrier model
11/09/2000WO2000028026A3 Gene expression modulated by opiate administration and withdrawal
11/09/2000WO2000027422A3 Methods and compositions for treating or preventing peripheral neuropathies
11/09/2000WO2000026381A3 High fidelity thermostable ligase and uses thereof
11/09/2000WO2000026367A3 Therapeutics and diagnostics for ocular abnormalities
11/09/2000WO2000026355A3 Construction of production strains for producing substituted phenols by specifically inactivating genes of the eugenol and ferulic acid catabolism
11/09/2000WO2000024780A3 Compositions and methods for treating polycystic kidney disease
11/09/2000WO2000024771A3 Nucleic acids encoding osteoprotegerin-like proteins and methods of using same
11/09/2000WO2000024765A3 Chlamydia antigens and corresponding dna fragments and uses thereof
11/09/2000WO2000024254A9 Compositions and methods for modulating expression within smooth muscle cells
11/09/2000WO2000023565A3 Novel neuropilin/growth factor binding and uses thereof
11/09/2000WO2000021996A3 Methods and compositions for inhibiting neoplastic cell growth
11/09/2000WO2000020571A9 Maize promoters
11/09/2000WO2000018929A3 Paramyxovirus vaccines
11/09/2000WO2000017342A3 Intron-mediated recombinant techniques and reagents
11/09/2000WO2000015826A3 Leptin induced genes
11/09/2000WO2000015785A3 GENE MODIFICATION IN THE GENE FOR THE DIE Gβ3-SUB-UNIT OF HUMAN G-PROTEIN
11/09/2000WO2000014112A3 Papillomaviruses, means for the detection thereof and therapy for diseases caused thereby
11/09/2000WO2000008209A3 Nucleic acids encoding human tbc-1 protein and polymorphic markers thereof
11/09/2000WO2000006737A8 Streptococcus pneumoniae proteins and nucleic acid molecules
11/09/2000WO2000004050A3 Neurotrophic growth factor
11/09/2000WO1999058671A3 Human and nematode homologues of the yeast longevity assurance gene lag1
11/09/2000WO1999056769A3 Inhibition of helicobacter pylori proliferation
11/09/2000WO1999055868A3 Fizz proteins
11/09/2000WO1999047678A9 Interferon alpha plasmids and delivery systems, and methods of making and using the same
11/09/2000DE19921027A1 Verbindungen mit antibiotischer Wirkung Compounds with antibiotic activity
11/09/2000DE19920712A1 Verfahren zum Herstellen eines rekombinanten Proteines A method for producing a recombinant Proteines
11/09/2000DE19920611A1 Modifying, cloning or amplifying cDNA comprises performing first strand synthesis in the presence of magnesium and manganese ions
1 ... 3158 3159 3160 3161 3162 3163 3164 3165 3166 3167 3168 3169 3170 3171 3172 3173 3174 3175 3176 3177 3178 ... 4023